EXICURE, INC. Operating Leases, Rent Expense, Minimum Rentals
EXICURE, INC. (XCUR) reported Operating Leases, Rent Expense, Minimum Rentals of $332.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeasesRentExpenseMinimumRentals · last filed 2020-03-10
- EXICURE, INC. operating leases, rent expense, minimum rentals for the quarter ending 2018-12-31 was $83.00K, a 0.00% change year-over-year.
- EXICURE, INC. operating leases, rent expense, minimum rentals for the quarter ending 2018-09-30 was $83.00K, a 0.00% change year-over-year.
- EXICURE, INC. operating leases, rent expense, minimum rentals for the quarter ending 2018-06-30 was $83.00K, a 0.00% change year-over-year.
- EXICURE, INC. operating leases, rent expense, minimum rentals for the quarter ending 2018-03-31 was $83.00K, a 0.00% change year-over-year.
- EXICURE, INC. operating leases, rent expense, minimum rentals for fiscal 2018 was $332.00K, a 0.00% change from fiscal 2017.
- EXICURE, INC. operating leases, rent expense, minimum rentals for fiscal 2017 was $332.00K, a 11.04% increase from fiscal 2016.
- EXICURE, INC. operating leases, rent expense, minimum rentals for fiscal 2016 was $299.00K.
| Period end | Operating Leases, Rent Expense, Minimum Rentals 3 month | Operating Leases, Rent Expense, Minimum Rentals 6 month | Operating Leases, Rent Expense, Minimum Rentals 9 month | Operating Leases, Rent Expense, Minimum Rentals 12 month |
|---|---|---|---|---|
| 2018-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $166.00K derived: sum of 2 quarters · filed 2020-03-10 | $249.00K derived: sum of 3 quarters · filed 2020-03-10 | $332.00K 10-K · filed 2020-03-10 |
| 2018-09-30 | $83.00K 10-Q · filed 2019-11-07 | $166.00K derived: sum of 2 quarters · filed 2019-11-07 | $249.00K 10-Q · filed 2019-11-07 | $332.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $83.00K 10-Q · filed 2019-08-08 | $166.00K 10-Q · filed 2019-08-08 | $249.00K derived: sum of 3 quarters · filed 2019-09-23 | $332.00K derived: sum of 4 quarters · filed 2019-09-23 |
| 2018-03-31 | $83.00K 10-Q · filed 2019-05-08 | $166.00K derived: sum of 2 quarters · filed 2019-09-23 | $249.00K derived: sum of 3 quarters · filed 2019-09-23 | $332.00K derived: sum of 4 quarters · filed 2019-09-23 |
| 2017-12-31 | $83.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-09-23 | $166.00K derived: sum of 2 quarters · filed 2019-09-23 | $249.00K derived: sum of 3 quarters · filed 2019-09-23 | $332.00K 10-K/A · filed 2019-09-23 |
| 2017-09-30 | $83.00K 10-Q · filed 2018-11-06 | $166.00K derived: sum of 2 quarters · filed 2018-11-06 | $249.00K 10-Q · filed 2018-11-06 | $332.00K derived: sum of 4 quarters · filed 2018-11-06 |
| 2017-06-30 | $83.00K 10-Q · filed 2018-08-06 | $166.00K 10-Q · filed 2018-08-06 | $249.00K derived: sum of 3 quarters · filed 2018-08-06 | $332.00K derived: sum of 4 quarters · filed 2018-08-06 |
| 2017-03-31 | $83.00K 10-Q · filed 2018-05-15 | $166.00K derived: sum of 2 quarters · filed 2018-05-15 | $249.00K derived: sum of 3 quarters · filed 2018-05-15 | |
| 2016-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $166.00K derived: sum of 2 quarters · filed 2018-03-09 | $299.00K 10-K · filed 2018-03-09 | |
| 2016-09-30 | $83.00K 10-Q · filed 2017-11-14 | $216.00K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |